The Oxford Centre for Early Cancer Detection (OxCODE) Funding Scheme aims to advance innovative Oxford-based research that can be applied to detecting cancer earlier. OxCODE provides short-term awards that will enable the development of proof-of-concept projects, technologies, assays and platforms to a stage at which more long-term external funding can be sought. Priority was given to projects with a clear translational trajectory towards the ultimate longer-term goal of improving cancer patient care through earlier detection.
After peer review by the OxCODE Operational Group and Oxford Cancer Patient and Public Involvement group, funds were allocated to the following projects:
- Professor Sarah Blagden (Department of Oncology) “Defining the immunopeptidomic landscape of ovarian cancer”.
- Professor Skirmantas Kriaucionis (Ludwig Institute for Cancer Research) “A pilot study to investigate prognostic biomarkers in patients with non-muscle invasive bladder cancer (NMIBC)”
Congratulations to these teams and thank you to all applicants for their submissions.